On September 11, 2025, Tempus AI, Inc. (NASDAQ: TEM) received FDA 510(k) clearance for its updated Tempus Pixel, an AI-powered cardiac imaging platform. The upgrade enables T1 and T2 inline mapping, providing detailed tissue characterization and helping clinicians detect fibrosis, inflammation, or edema that standard MR images may miss. By automating reporting and improving accuracy, Tempus Pixel exemplifies how AI is reshaping cardiac MRI and precision medicine.
As healthcare systems embrace value-based care, advances like AI-enabled imaging, portable MRI scanners, and hybrid systems are accelerating adoption. Supported by ongoing R&D investments and expanding global access, the MRI devices market is projected to grow at a CAGR of ~6.54% through 2032.
DelveInsight’s Magnetic Resonance Imaging (MRI) Devices Market Insights report offers an in-depth analysis of market dynamics, growth drivers, regulatory updates, competitive landscape, and leading companies shaping the future of MRI technology.
Key Takeaways from the Magnetic Resonance Imaging Market Report
• The magnetic resonance imaging (MRI) devices market was valued at USD 8.21 billion in 2024 and is projected to grow at a CAGR of 6.54% from 2025 to 2032, reaching USD 13.55 billion by 2032.
• As per DelveInsight estimates, North America is anticipated to dominate the global magnetic resonance imaging market during the forecast period.
• Notable magnetic resonance imaging companies such as General Electric Company, FUJIFILM Holdings Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, ESAOTE SPA, Aspect Imaging Ltd., Bruker Corporation, Aurora Healthcare US Corp., FONAR Corp., Neusoft Medical Systems Co., Ltd., Shenzhen Anke High-Tech Co. Ltd., Shenzhen Basda Medical Apparatus Co. Ltd., Time Medical Holding, Hyperfine, Alltech Medical Systems, InnerVision MRI Ltd., Magnetica Limited, IMRIS, Deerfield Imaging, Inc., and several others are currently operating in the Magnetic Resonance Imaging market.
• In September 2025, Tempus AI (NASDAQ: TEM) received FDA 510(k) clearance for its updated Tempus Pixel, an AI-powered cardiac imaging platform. The update adds T1 and T2 inline map generation, enhancing cardiac MRI image analysis capabilities.
• In September 2025, Tempus AI (NASDAQ: TEM) received FDA 510(k) clearance for its updated Tempus Pixel, an AI-powered cardiac imaging platform. The update adds T1 and T2 inline map generation, enhancing cardiac MRI image analysis capabilities.
• In February 2025, Prenuvo, the leader in proactive whole-body MRI screening, disclosed raising $120M in Series B funding, underscoring its leadership in preventative health. The company has identified over 1.4 million personalized health insights across its member base, emphasizing the importance of early detection.
• In February 2025, Subtle Medical, the global leader in AI-powered medical imaging enhancement, announced FDA clearance for Subtle-HD™, the most advanced MRI acceleration and enhancement software to date.
• In February 2025, Ezra, the healthcare AI startup focused on early cancer detection through full-body MRI screening, announced that its advanced Ezra Flash AI model received 510(k) clearance from the U.S. FDA.
To read more about the latest highlights related to the Magnetic Resonance Imaging market, get a snapshot of the key highlights entailed in the Global Magnetic Resonance Imaging Market Report
Magnetic Resonance Imaging Overview
Magnetic Resonance Imaging (MRI) is a non-invasive diagnostic technique that uses strong magnetic fields and radio waves to create detailed images of organs, tissues, and internal structures. It is widely used in neurology, cardiology, oncology, and musculoskeletal imaging for its high-resolution, contrast-rich visuals without radiation exposure.
MRI devices range from low-field to high-field systems and now often include advanced features like AI-powered image analysis, faster scanning times, and functional imaging capabilities. As technology advances, MRI continues to play a critical role in early diagnosis, treatment planning, and ongoing disease monitoring.
Magnetic Resonance Imaging Market Insights
North America is expected to dominate the Magnetic Resonance Imaging market from 2023 through 2024, as the region is projected to lead the global MRI devices market in 2024. This dominance is driven by the high prevalence of neurological disorders, cardiovascular diseases, and cancer, coupled with rapid technological advancements and the strong regional presence of key industry players. The increasing burden of neurodegenerative diseases like Alzheimer’s and Parkinson’s—affecting millions in the U.S.—is boosting demand for MRI’s advanced imaging capabilities, including fMRI and MRS, for early diagnosis and monitoring.
Cancer cases are also rising, with GLOBOCAN estimating 2.67 million new cases in 2022 and projections reaching 3.83 million by 2045. MRI’s superior imaging for complex anatomical areas like the brain and pelvis makes it critical in cancer detection and treatment planning.
Innovations such as Siemens Healthineers’ FDA-cleared MAGNETOM Cima.X 3T MRI scanner, featuring the most powerful gradient system for clinical use, highlight ongoing technological progress. Alongside product launches, strategic partnerships, and government initiatives to enhance diagnostic infrastructure, these factors are set to fuel sustained growth in the North American MRI market.
To know more about why North America is leading the market growth in the Magnetic Resonance Imaging market, get a snapshot of the Magnetic Resonance Imaging Market Outlook
Magnetic Resonance Imaging Market Dynamics
According to GLOBOCAN (2024), global cancer cases reached 20 million in 2022 and are projected to rise to 32.6 million by 2045, significantly driving demand for MRI devices. MRI plays a crucial role in oncology by providing detailed, radiation-free imaging for detecting tumors in areas like the brain, breast, liver, and prostate. Its ability to evaluate tumor size and disease stage makes it vital for cancer care.
In neurological imaging, MRI is equally essential. Brain and CNS cancers reached 322,000 cases globally in 2022, expected to rise to 474,000 by 2045. Additionally, the British Heart Foundation (2024) reports 100 million global stroke survivors. Advanced MRI techniques like diffusion-weighted imaging (DWI) support early stroke diagnosis and help guide timely treatment, enhancing patient outcomes.
Technological innovation continues to strengthen the market. For example, Hitachi’s 2021 launch of open MRI systems with SynergyDrive improved imaging speed and comfort. However, growth may be challenged by product recalls and regulatory hurdles, which can delay adoption and impact trust.
Overall, rising disease prevalence, innovation, and MRI’s non-invasive advantages are fueling market growth, though maintaining quality and navigating regulatory landscapes remain key to sustained progress.
Get a sneak peek at the Magnetic Resonance Imaging market dynamics @ https://www.delveinsight.com/report-store/magnetic-resonance-imaging-devices-market
Coverage: Global
Study Period: 2022 to 2032
Magnetic Resonance Imaging Market CAGR: ~6.54%
Key Magnetic Resonance Imaging Companies: General Electric Company, FUJIFILM Holdings Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, ESAOTE SPA, Aspect Imaging Ltd., Bruker Corporation, Aurora Healthcare US Corp., FONAR Corp., Neusoft Medical Systems Co., Ltd., Shenzhen Anke High-Tech Co. Ltd., Shenzhen Basda Medical Apparatus Co. Ltd., Time Medical Holding, Hyperfine, Alltech Medical Systems, InnerVision MRI Ltd., Magnetica Limited, IMRIS, Deerfield Imaging, Inc., and others.
Magnetic Resonance Imaging Market Segmentation
Market Segmentation By Field Strength: High-Field MRI Systems (1.5t to 3t), Low-to-Mid-Field MRI Systems (<1.5t), and Very-High-Field MRI Systems (4t And Above).
Market Segmentation By Architecture: Closed MRI Systems, Wide-Bore MRI, and Open MRI Systems.
Market Segmentation By Application: Musculoskeletal, Gastroenterology, Neurology, Oncology, and Others
Market Segmentation By End User: Hospitals, Diagnostic Centers, and others.
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World.
Which MedTech key players in the Magnetic Resonance Imaging market are set to emerge as the trendsetter, explore @ Magnetic Resonance Imaging Companies
Table of Contents
1. Electrophysiology Devices Market Report Introduction
2. Electrophysiology Devices Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Electrophysiology Devices Market Key Factors Analysis
6. Electrophysiology Devices Market Porter’s Five Forces Analysis
7. Electrophysiology Devices Market Layout
8. Electrophysiology Devices Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.
Media Contact
Company Name: DelveInsight
Contact Person: Jatin Vimal
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/